320 related articles for article (PubMed ID: 26827949)
1. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
2. Modulators of vitamin D nuclear receptor: recent advances from structural studies.
Belorusova AY; Rochel N
Curr Top Med Chem; 2014; 14(21):2368-77. PubMed ID: 25486941
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
4. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor 2016: novel ligands and structural insights.
Maestro MA; Molnár F; Mouriño A; Carlberg C
Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
[TBL] [Abstract][Full Text] [Related]
6. Minireview: vitamin D receptor: new assignments for an already busy receptor.
Norman AW
Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of hereditary vitamin D-resistant rickets--associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand.
Rochel N; Hourai S; Moras D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):84-7. PubMed ID: 20403435
[TBL] [Abstract][Full Text] [Related]
8. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor modulators for inflammation and cancer.
Yee YK; Chintalacharuvu SR; Lu J; Nagpal S
Mini Rev Med Chem; 2005 Aug; 5(8):761-78. PubMed ID: 16101412
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
11. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
Peräkylä M; Malinen M; Herzig KH; Carlberg C
Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
[TBL] [Abstract][Full Text] [Related]
12. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals.
Adachi R; Shulman AI; Yamamoto K; Shimomura I; Yamada S; Mangelsdorf DJ; Makishima M
Mol Endocrinol; 2004 Jan; 18(1):43-52. PubMed ID: 14525957
[TBL] [Abstract][Full Text] [Related]
14. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
16. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
17. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
Ikura T; Ito N
Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
[TBL] [Abstract][Full Text] [Related]
19. Structural development of p-carborane-based potent non-secosteroidal vitamin D analogs.
Fujii S; Sekine R; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem; 2014 Nov; 22(21):5891-901. PubMed ID: 25284253
[TBL] [Abstract][Full Text] [Related]
20. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report.
Norman AW; Bishop JE; Collins ED; Seo EG; Satchell DP; Dormanen MC; Zanello SB; Farach-Carson MC; Bouillon R; Okamura WH
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):13-22. PubMed ID: 8603033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
